RETAVASE Trademark

Trademark Overview


On Friday, March 15, 2019, a trademark application was filed for RETAVASE with the United States Patent and Trademark Office. The USPTO has given the RETAVASE trademark a serial number of 88341695. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2019. This trademark is owned by EKR THERAPEUTICS, INC.. The RETAVASE trademark is filed in the Pharmaceutical Products category with the following description:

cardiovascular agents for medical purposes, namely, a recombinant plasminogen activator compound for use in the management of acute myocardial infarction
retavase

General Information


Serial Number88341695
Word MarkRETAVASE
Filing DateFriday, March 15, 2019
Status700 - REGISTERED
Status DateTuesday, September 10, 2019
Registration Number5857585
Registration DateTuesday, September 10, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 25, 2019

Trademark Statements


Goods and Servicescardiovascular agents for medical purposes, namely, a recombinant plasminogen activator compound for use in the management of acute myocardial infarction

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 3, 2019
Primary Code005
First Use Anywhere DateThursday, January 2, 1997
First Use In Commerce DateThursday, January 2, 1997

Trademark Owner History


Party NameCHIESI USA, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCARY, NC 27518

Party NameEKR THERAPEUTICS, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWILMINGTON, DE 19808

Party NameEKR THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCary, NC 27518

Party NameEKR THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCary, NC 27518

Party NameEKR THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCary, NC 27518

Trademark Events


Event DateEvent Description
Thursday, April 18, 2019ASSIGNED TO PETITION STAFF
Tuesday, March 19, 2019NEW APPLICATION ENTERED
Wednesday, March 20, 2019TEAS REQUEST TO MAKE SPECIAL RECEIVED
Wednesday, April 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 23, 2019REQUEST FOR SPECIAL HANDLING - GRANTED
Tuesday, April 23, 2019ASSIGNED TO EXAMINER
Tuesday, April 23, 2019ASSIGNED TO EXAMINER
Monday, April 29, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, April 29, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, May 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 16, 2019ASSIGNED TO LIE
Wednesday, June 5, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 25, 2019PUBLISHED FOR OPPOSITION
Tuesday, June 25, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, August 18, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 29, 2019EXAMINERS AMENDMENT E-MAILED
Monday, April 29, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 10, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 26, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 24, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP